Clinical Trial Update: Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating tamoxifen for preventing breast cancer in women at increased risk was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED